Revolution Medicines Inc (RVMD : NASDAQ)
Common Stock
$189.26
USD
-4.26 (-2.20%)
Last updated: 2026-10-15
Follow RVMD
RVMD
Revolution Medicines Inc
WealthAwesomePerformance
1 Day
-2.20%
1 Week
+0.61%
1 Month
-7.61%
YTD
+139.51%
Key Statistics
Market Cap
$40.57B
52W High
$224.31
52W Low
$52.48
P/E Ratio
-
50 Day MA
$203.68
200 Day MA
$150.58
Beta
1.40
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/15/2026 | $193.31 | $195.94 | $189.14 | $189.26 | $189.26 | 1,568,008 |
| 10/14/2026 | $186.84 | $197.00 | $185.88 | $193.52 | $193.52 | 2,463,046 |
| 10/13/2026 | $191.57 | $193.61 | $187.14 | $188.44 | $188.44 | 2,939,058 |
| 10/12/2026 | $187.79 | $194.26 | $184.76 | $193.95 | $193.95 | 1,667,288 |
| 10/9/2026 | $186.01 | $193.50 | $184.37 | $189.76 | $189.76 | 2,210,300 |
| 10/8/2026 | $198.51 | $199.64 | $180.49 | $188.12 | $188.12 | 4,855,046 |
| 10/7/2026 | $198.18 | $203.50 | $196.25 | $200.87 | $200.87 | 1,185,197 |
| 10/6/2026 | $208.57 | $208.57 | $195.00 | $199.87 | $199.87 | 1,631,360 |
| 10/5/2026 | $207.68 | $210.27 | $201.83 | $207.68 | $207.68 | 1,424,236 |
| 10/2/2026 | $205.89 | $208.82 | $204.07 | $206.64 | $206.64 | 1,570,300 |
Analyst Price Targets
Based on 24 analysts covering RVMD · as of Oct 16, 2026
Wall Street analysts forecast RVMD stock price to rise 36.9% over the next 12 months.
Consensus
Strong Buy4.71 / 5.00
Avg. Target
US$259.18
+36.9% Upside
Previously US$259.14 on Oct 12, 2026
Current Price
US$189.26
Last close
Analyst Breakdown (24 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on RVMD's historical volatility
30-Day Vol
36.4%
Annualized
90-Day Vol
39.3%
Annualized
Trend (90d)
+14.1%
Annualized drift
90d Mean
US$199.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$192.45 | US$169.71 – US$218.24 |
| 60 trading days | US$195.70 | US$163.82 – US$233.79 |
| 90 trading days | US$199.00 | US$160.06 – US$247.43 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Revolution Medicines Inc
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Financials
- Revenue (TTM)
- $742,000
- EBITDA
- $-1.62B
- Profit Margin
- 0.00%
- ROE (TTM)
- -79.09%
- EPS (Diluted)
- -8.87
- Book Value
- 12.16
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About RVMD.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| KNDI | Kandi Technologies Group Inc | $4.11 | +928.50% |
| ESLA | Estrella Immunopharma Inc. | $0.54 | +68.35% |
| SDST | Stardust Power Inc. | $0.04 | +55.38% |
| XLAB | Exascale Labs Holdings Inc. Class A Common Stock | $1.36 | +49.70% |
| WETO | Webus International Limited Ordinary Shares | $1.22 | +46.88% |
| RITRF | Reitar Logtech Holdings Limited | $0.02 | +40.85% |
| DRMA | Dermata Therapeutics Inc | $0.91 | +37.19% |
| LESLQ | Leslie's, Inc. | $0.03 | +35.75% |
RVMD.US news timeline
3 articles covering RVMD.US, most recent first
Latest